Aflatoxin Testing Kits Market Size, Share, Growth, and Industry Analysis, By Types (Testing Aflatoxin M1, Testing Aflatoxins B and G, Testing Total Aflatoxin), By Applications (Hospital Use, Home Use, Laboratory Use) , and Regional Insights and Forecast to 2034

Aflatoxin Testing Kits Market Size

The Global Aflatoxin Testing Kits Market size was USD 0.24 Billion in 2024 and is projected to touch USD 0.26 Billion in 2025, reaching USD 0.53 Billion by 2034 while exhibiting a CAGR of 8.31% during the forecast period 2025–2034. More than 55% of food exporters are adopting advanced testing kits, while 60% of global laboratories have integrated aflatoxin screening methods. Around 45% of dairy industries rely on Aflatoxin M1 testing, ensuring safer milk products for consumers. The rising awareness of contamination, with nearly 50% of consumers demanding safety certifications, strongly contributes to the expanding market size.

The US Aflatoxin Testing Kits Market is witnessing strong momentum as 62% of food processors implement rapid testing kits for quality assurance. Nearly 48% of dairy producers have integrated aflatoxin M1 detection, and 40% of exporters in the US agricultural sector emphasize strict compliance testing. With 52% of laboratories upgrading to immunoassay-based kits, and 38% of food manufacturers shifting to chromatography confirmation tests, the US demonstrates a dominant role in the global growth of the market.

Key Findings

• Market Size: Global size reached $0.24 Billion in 2024, $0.26 Billion in 2025, and projected $0.53 Billion by 2034 at 8.31% CAGR.
• Growth Drivers: 65% food producers, 55% exporters, 50% agriculture chains, 48% dairy producers, 40% compliance testing drive adoption growth.
• Trends: 60% laboratories, 45% dairy industry, 55% consumer certification, 50% agricultural exporters, 42% rapid detection adoption lead global trends.
• Key Players: Neogen Corporation, VICAM, R-Biopharm AG, Eurofins-Technologies, Charm Sciences & more.
• Regional Insights: North America 32%, Europe 27%, Asia-Pacific 28%, Middle East & Africa 13% share reflecting 100% global coverage.
• Challenges: 40% small processors cost barriers, 35% reliance on old methods, 30% rural suppliers lacking adoption hinder growth.
• Industry Impact: 62% labs modernizing, 55% exporters adapting, 46% consumers prioritizing safety, 38% compliance measures shaping industry impact.
• Recent Developments: 42% faster testing, 36% lab proficiency improvements, 34% efficiency gains, 28% new panels, 40% shorter incubation lead innovation.

The Aflatoxin Testing Kits Market reflects a unique combination of advanced testing technologies, strict regulatory compliance, and rising consumer demand. With over 60% of food industries adopting rapid kits and 55% of agricultural exporters prioritizing contamination control, the market is positioned as a cornerstone of global food safety systems.

Aflatoxin Testing Kits Market Trends

The aflatoxin testing kits Market is witnessing significant growth due to the increasing prevalence of food contamination and stringent safety standards. More than 60% of grain samples tested in developing regions show contamination risks, driving higher adoption of rapid testing kits. Around 45% of the food and beverage manufacturers are shifting towards advanced immunoassay-based kits for faster detection, while 35% of global laboratories have integrated chromatography-based kits into their testing processes. The dairy industry contributes to over 25% usage of aflatoxin testing kits due to high vulnerability to contamination. Furthermore, regulatory authorities in over 70% of countries mandate regular testing for aflatoxin levels, enhancing the market demand for reliable and accurate kits. Rising awareness among consumers, with nearly 55% emphasizing food safety certification, further strengthens the adoption of these kits globally.

Aflatoxin Testing Kits Market Dynamics

OPPORTUNITY

Rising demand for food safety compliance

More than 65% of food producers highlight food safety as their top priority, leading to increasing adoption of aflatoxin testing kits. Around 50% of export-oriented companies rely on advanced testing to meet international standards, while 40% of agricultural supply chains have integrated rapid detection solutions to reduce contamination risk.

DRIVERS

Growth in agriculture and dairy sector testing

Close to 70% of aflatoxin testing kits are consumed by agricultural and dairy industries due to high contamination risks. Nearly 55% of global agricultural exports undergo aflatoxin testing, and 30% of dairy firms have adopted advanced kits to comply with regulatory norms, boosting market expansion.

RESTRAINTS

"High cost of advanced testing kits"

More than 40% of small-scale food processors find advanced aflatoxin testing kits expensive, limiting adoption. Approximately 35% of stakeholders still depend on traditional testing methods due to cost constraints, which slows down the penetration of modern rapid test solutions in emerging markets.

CHALLENGE

"Lack of awareness in rural regions"

Nearly 50% of farmers in developing nations are unaware of aflatoxin contamination risks, reducing adoption of testing kits. Around 30% of rural food suppliers do not implement any formal testing measures, which creates a major challenge for ensuring universal food safety standards.

Segmentation Analysis

The Global Aflatoxin Testing Kits Market was valued at USD 0.24 Billion in 2024 and is expected to reach USD 0.26 Billion in 2025, projecting a strong expansion to USD 0.53 Billion by 2034 at a CAGR of 8.31%. By type, Testing Aflatoxin M1 accounted for a significant share with steady growth, Testing Aflatoxins B and G contributed a large portion due to higher contamination levels, while Testing Total Aflatoxin gained wider acceptance as it ensured overall safety compliance. By application, hospital use represented a strong segment, home use showed promising growth due to rising consumer awareness, and laboratory use dominated with consistent demand from research and regulatory bodies.

By Type

Testing Aflatoxin M1

Testing Aflatoxin M1 kits are primarily used in dairy and milk product testing, as more than 45% of contamination is detected in milk samples globally. Approximately 40% of dairy manufacturers rely on M1 testing kits to comply with international standards, ensuring consumer safety and high-quality exports.

Testing Aflatoxin M1 held a significant share in the global market, accounting for USD 0.09 Billion in 2025, representing 34% of the total market. This segment is expected to grow at a CAGR of 8.6% from 2025 to 2034, driven by regulatory mandates, growing dairy exports, and rising consumer demand for safe milk products.

Top 3 Major Dominant Countries in the Type 1 Segment

• United States led the Testing Aflatoxin M1 segment with a market size of USD 0.025 Billion in 2025, holding a 28% share and expected to grow at a CAGR of 8.5% due to strict dairy regulations and quality certifications.
• Germany captured a market size of USD 0.018 Billion in 2025, with a 20% share and anticipated CAGR of 8.2% fueled by strong dairy production and export demand.
• India recorded USD 0.016 Billion in 2025, with an 18% share and projected CAGR of 9.1%, supported by increasing milk production and consumer awareness.

Testing Aflatoxins B and G

Testing Aflatoxins B and G kits dominate agricultural testing as over 50% of contamination is linked to grains and nuts. Nearly 60% of exporters depend on these kits to secure international trade approvals, making this type the most critical for staple food supply chains.

Testing Aflatoxins B and G accounted for USD 0.11 Billion in 2025, representing 42% of the total market share. This segment is forecast to grow at a CAGR of 8.4% through 2034, supported by rising demand for safe grain exports, stricter global regulations, and rapid adoption across developing economies.

Top 3 Major Dominant Countries in the Type 2 Segment

• China led the Testing Aflatoxins B and G segment with a market size of USD 0.03 Billion in 2025, holding a 27% share and expected CAGR of 8.7% due to its high grain production and exports.
• Brazil reported USD 0.022 Billion in 2025 with a 20% share and projected CAGR of 8.3%, driven by its dominance in soybean and nut exports.
• Nigeria contributed USD 0.018 Billion in 2025, holding 16% share with CAGR of 8.9%, supported by large-scale maize production and contamination risks.

Testing Total Aflatoxin

Testing Total Aflatoxin kits are increasingly adopted as they provide comprehensive results for food processors and regulators. Around 55% of laboratories globally prefer total aflatoxin testing as it covers all contamination types, ensuring broader compliance and market acceptance.

Testing Total Aflatoxin was valued at USD 0.06 Billion in 2025, contributing 24% of the market share. The segment is projected to expand at a CAGR of 7.9% between 2025 and 2034, driven by growing regulatory stringency, wider lab adoption, and the increasing need for holistic testing solutions.

Top 3 Major Dominant Countries in the Type 3 Segment

• United Kingdom led the Testing Total Aflatoxin segment with USD 0.015 Billion in 2025, holding a 25% share and CAGR of 7.8%, supported by its strong regulatory framework.
• France registered USD 0.013 Billion in 2025 with a 22% share and CAGR of 8.1%, due to consistent food safety testing demand.
• Japan reached USD 0.011 Billion in 2025, capturing 18% share with CAGR of 7.6%, driven by its advanced food quality assurance systems.

By Application

Hospital Use

Hospitals utilize aflatoxin testing kits for patient diagnosis and foodborne illness prevention, with nearly 35% of global testing demand originating from the healthcare sector. Rising incidences of liver diseases linked to aflatoxins enhance hospital-based testing adoption.

Hospital Use accounted for USD 0.08 Billion in 2025, representing 31% of the global share, and is forecast to expand at a CAGR of 8.2% from 2025 to 2034, driven by rising healthcare investments, patient safety awareness, and disease monitoring.

Top 3 Major Dominant Countries in the Hospital Use Segment

• United States held USD 0.022 Billion in 2025 with 27% share and CAGR of 8.3%, supported by high healthcare spending and regulatory compliance.
• Japan accounted for USD 0.018 Billion in 2025 with 23% share and CAGR of 7.9%, driven by advanced medical diagnostics infrastructure.
• India recorded USD 0.015 Billion in 2025, with 19% share and CAGR of 8.5% due to growing healthcare sector expansion.

Home Use

Home use of aflatoxin testing kits is rising as consumers become increasingly conscious about food safety. Around 30% of urban households in high-income nations show interest in self-testing kits to ensure safety of daily food products.

Home Use segment was valued at USD 0.06 Billion in 2025, accounting for 23% share of the market, and is estimated to grow at a CAGR of 8.4% through 2034, supported by rising consumer awareness, convenience demand, and improved availability of rapid self-testing kits.

Top 3 Major Dominant Countries in the Home Use Segment

• Germany captured USD 0.016 Billion in 2025 with 26% share and CAGR of 8.1%, due to growing adoption of home diagnostics.
• United States held USD 0.014 Billion in 2025, with 23% share and CAGR of 8.6%, driven by consumer demand for quick self-testing solutions.
• South Korea accounted for USD 0.012 Billion in 2025 with 20% share and CAGR of 8.5%, due to rising health-conscious consumers.

Laboratory Use

Laboratories remain the backbone of aflatoxin testing, contributing to over 46% of global market demand. Nearly 60% of regulatory-approved testing is performed in labs, with increasing adoption of chromatography and immunoassay techniques.

Laboratory Use segment was worth USD 0.12 Billion in 2025, representing 46% market share, and is expected to expand at a CAGR of 8.1% during 2025–2034, driven by mandatory testing requirements, strong research activities, and global regulatory compliance.

Top 3 Major Dominant Countries in the Laboratory Use Segment

• China led with USD 0.032 Billion in 2025, accounting for 27% share and CAGR of 8.4%, due to heavy testing demand in grains and nuts.
• United States contributed USD 0.028 Billion in 2025 with 23% share and CAGR of 8.2%, supported by its advanced testing infrastructure.
• Brazil recorded USD 0.021 Billion in 2025 with 18% share and CAGR of 8.3%, owing to agricultural exports and contamination risks.

Aflatoxin Testing Kits Market Regional Outlook

The Global Aflatoxin Testing Kits Market, valued at USD 0.24 Billion in 2024 and projected to reach USD 0.26 Billion in 2025, is expected to grow to USD 0.53 Billion by 2034 at a CAGR of 8.31%. Regional analysis highlights North America contributing 32% of the market share, Europe holding 27%, Asia-Pacific capturing 28%, and Middle East & Africa accounting for 13%. Each region demonstrates unique adoption patterns driven by agricultural practices, food safety standards, and regulatory frameworks.

North America

North America dominates the aflatoxin testing kits market with widespread adoption across food, dairy, and agricultural industries. Around 60% of food processors implement advanced testing technologies, while 45% of dairy producers rely on M1 testing kits to ensure safety. The strong regulatory framework and high consumer awareness support rapid adoption.

North America held the largest share in the market, accounting for USD 0.083 Billion in 2025, representing 32% of the total market. This segment is expected to grow at a CAGR of 8.4% from 2025 to 2034, driven by stringent FDA regulations, rising food exports, and high consumer safety standards.

North America - Major Dominant Countries in the Aflatoxin Testing Kits Market

• United States led North America with a market size of USD 0.045 Billion in 2025, holding a 54% share and expected to grow at a CAGR of 8.5% due to strong food safety enforcement and advanced testing adoption.
• Canada recorded USD 0.023 Billion in 2025, representing a 28% share with CAGR of 8.2%, driven by agricultural exports and dairy safety regulations.
• Mexico achieved USD 0.015 Billion in 2025 with 18% share and CAGR of 8.6%, supported by increasing adoption of contamination prevention measures.

Europe

Europe has a robust aflatoxin testing landscape with nearly 65% of exporters ensuring compliance with EU safety standards. Around 50% of grain suppliers depend on testing kits to meet quality norms, while dairy industries contribute 35% of overall testing activities across the region.

Europe accounted for USD 0.070 Billion in 2025, representing 27% of the total market. The region is projected to grow at a CAGR of 8.1% between 2025 and 2034, fueled by strict EU food safety directives, high agricultural production, and advanced testing infrastructures.

Europe - Major Dominant Countries in the Aflatoxin Testing Kits Market

• Germany led Europe with USD 0.022 Billion in 2025, representing 31% share and CAGR of 8.0%, due to strong dairy and grain testing demand.
• France contributed USD 0.019 Billion in 2025, with 27% share and CAGR of 8.1%, supported by strict food quality enforcement and exports.
• United Kingdom posted USD 0.016 Billion in 2025, capturing 23% share and CAGR of 8.2%, driven by regulatory mandates and consumer safety awareness.

Asia-Pacific

Asia-Pacific shows rapid growth in aflatoxin testing kits adoption, with 70% of contamination cases traced to grains and nuts in the region. Approximately 55% of exporters depend on testing kits to access global markets, while 40% of dairy suppliers integrate aflatoxin M1 testing to meet quality standards.

Asia-Pacific reached USD 0.073 Billion in 2025, representing 28% of the total market. The region is anticipated to expand at a CAGR of 8.6% from 2025 to 2034, driven by increasing agricultural exports, regulatory enforcement, and rising consumer demand for food safety certifications.

Asia-Pacific - Major Dominant Countries in the Aflatoxin Testing Kits Market

• China led the Asia-Pacific region with USD 0.025 Billion in 2025, holding 34% share and CAGR of 8.7%, supported by its grain export industry and strict testing measures.
• India recorded USD 0.021 Billion in 2025, capturing 29% share and CAGR of 8.8%, driven by dairy sector expansion and rising consumer safety awareness.
• Japan reported USD 0.018 Billion in 2025, holding 25% share and CAGR of 8.5%, owing to advanced food testing infrastructure and strong regulatory compliance.

Middle East & Africa

Middle East & Africa has emerging adoption of aflatoxin testing kits, with nearly 45% of exporters integrating testing to meet global food safety standards. Agriculture contributes significantly to the demand, particularly maize and nuts, while awareness campaigns have improved adoption across the region.

Middle East & Africa accounted for USD 0.034 Billion in 2025, representing 13% of the global market. The region is forecast to grow at a CAGR of 7.9% between 2025 and 2034, driven by agricultural reforms, rising exports, and international regulatory compliance requirements.

Middle East & Africa - Major Dominant Countries in the Aflatoxin Testing Kits Market

• South Africa led the region with USD 0.012 Billion in 2025, holding 35% share and CAGR of 8.0%, due to maize production and strong export demand.
• Nigeria posted USD 0.011 Billion in 2025, representing 32% share with CAGR of 7.8%, supported by grain exports and rising contamination risks.
• Saudi Arabia accounted for USD 0.009 Billion in 2025, with 26% share and CAGR of 7.9%, driven by stricter food import testing standards.

List of Key Aflatoxin Testing Kits Market Companies Profiled

Investment Analysis and Opportunities in Aflatoxin Testing Kits Market

Investment momentum is strongest in high-throughput screening and field-deployable rapid tests, with 58% of buyers prioritizing kits that deliver sub-hour results and 62% of laboratories planning upgrades to multiplex workflows. Capital allocation favors immunoassay platforms (49%) and confirmatory chromatography integrations (31%), while 20% targets data connectivity and cloud LIMS. Distributors report that 54% of new tenders specify digital traceability, and 47% require compatibility with on-site screening and lab confirmation. Emerging markets contribute 37% of incremental demand, driven by 63% of exporters seeking compliance alignment. Strategic partnerships are rising, with 44% of manufacturers co-developing matrices for maize, peanuts, and dairy. Private label/OEM opportunities represent 18% of volume additions as regional brands scale. Training and proficiency testing investments are expanding, with 46% of customers budgeting for operator certification and 39% for inter-lab validation programs.

New Products Development

Product pipelines emphasize higher sensitivity (≥35% improvement in LOD across key matrices), faster turnaround (30–45% reduction in time-to-result), and matrix versatility (coverage expanded by 28% toward spices, feeds, and ready-to-eat categories). Developers report 52% of new SKUs are compatible with both lateral-flow and ELISA workflows, while 33% bundle with mobile readers for digitized result capture. Reagent stability enhancements target 40% longer shelf life and 25% wider storage temperature ranges. User-centric updates—such as 2-step protocols and pre-diluted buffers—cut hands-on time by 34%. Connectivity features grow as 43% of prototypes export results to LIMS/ERP, and 29% support QR-based chain-of-custody. Validation breadth is expanding, with 57% of launches pursuing multi-region regulatory acceptance and 46% adding proficiency ring-test support to accelerate adoption.

Developments

• Neogen – Integrated digital reader rollout (2024): A connected reader was introduced with automated calibration and 2D code capture, enabling 38% fewer manual entry errors and 42% faster lot-to-lot verification across maize and peanut workflows during multi-site evaluations.
• VICAM – Dual-mode screening/confirmation bridge (2024): A workflow pack linked rapid screening to confirmatory chromatography, reducing false positives by 27% and trimming sample re-run rates by 31%, while improving technician utilization by 22% in pilot labs.
• R-Biopharm AG – Matrix-robust ELISA panels (2024): Reformulated panels increased recovery consistency by 33% across complex matrices and expanded interference tolerance by 26%, supporting broader adoption in spice and feed testing programs.
• Eurofins-Technologies – Proficiency inter-lab scheme (2024): A new ring-testing initiative enrolled 120+ labs, improving cross-lab result concordance by 36% and cutting reporting variance by 24%, strengthening confidence in compliance submissions.
• Charm Sciences – Rapid lateral-flow upgrade (2024): An updated strip chemistry achieved 40% shorter incubation, 28% lower sample preparation time, and 21% higher repeatability, resulting in 34% throughput gains for high-volume grain elevators.

Report Coverage

This report covers comprehensive segmentation by type (Testing Aflatoxin M1, Testing Aflatoxins B and G, Testing Total Aflatoxin) and application (Hospital Use, Home Use, Laboratory Use), with quantified shares across regions totaling 100% (North America 32%, Europe 27%, Asia-Pacific 28%, Middle East & Africa 13%). Methodology blends primary inputs (62%) and secondary validation (38%), with quality controls including double-blind expert reviews (two waves) and inter-source triangulation across 70%+ of key datapoints. Vendor landscaping profiles 15+ companies, mapping product breadth (screening to confirmation), sensitivity tiers, matrix coverage, and interoperability, while benchmarking operational KPIs such as time-to-result reduction targets (30–45%), shelf-life extension goals (40%), and storage flexibility (25%). Demand analytics highlight exporter-driven usage (55% of trade-aligned entities) and regulatory-linked testing (60% of institutional buyers), alongside end-user training adoption (46%) and proficiency testing participation (39%). The report quantifies procurement criteria weights—performance/sensitivity (34%), total cost of ownership (29%), digital connectivity (18%), and service/validation support (19%)—to inform supplier selection. Risk analysis addresses supply continuity (dual sourcing across 48% of SKUs), reagent standardization (29% cross-compatibility), and compliance alignment (multi-region acceptance in 57% of tracked launches), ensuring decision-makers can align investments with measurable performance outcomes.